Items of recent pandemic news: Boosters approved for kids 5-11; the cause of severe Covid-19; two new vaccines built on different technology bases; immune evasiveness of two Omicron sub-variants; Paxlovid developments; and much more. Plus a frippery. The pandemic sputters … Continue reading →
Nine items of recent pandemic news you may have missed: Rapid testing, mixing and matching vaccines, booster shots, the genetics predicting severe Covid-19, another blow to J&J, some mechanisms behind neurological damage, and more. Plus a frippery. 1. Pfizer wants … Continue reading →
Items of recent pandemic news: Moderna applies to the FDA for full licensure; Minnesota and the Twin Cities end mask mandates; and cautious optimism that the pandemic is ending in the US. Plus news briefs and a brace of fripperies. … Continue reading →
Herewith three items of recent pandemic news: More studies on mixing vaccine doses; the FDA extends Pfizer’s authorization to ages 12+; and acknowledgement from the CDC that this virus is airborne. Plus news briefs and a frippery. It is indeed … Continue reading →
Three items of pandemic news you may have missed recently: Moderna can pack more doses per vial; Emergent’s big mistake; and news on vaccines for kids as young as 12. Plus news briefs and a pair of fripperies. Pfizer is … Continue reading →
Herewith three items of pandemic news you may have missed recently: A trial of mixed shots begins in the UK; a sobering tale of a variant’s spread; and J&J applies for an EUA. Plus news briefs and a frippery. Johnson … Continue reading →
Not only has the UK approved the AstraZeneca / Oxford vaccine candidate, on what many specialists consider thin evidence from a bungled trial, they are embarking on a grand epidemiological experiment: seeing how well covering more people with a single … Continue reading →
